Turning scientific breakthroughs into real-world therapeutics
Science that humanity deserves
We commit to science that matters. We back breakthroughs that are technically demanding and clinically meaningful. We choose carefully, stay deeply involved, and help build the kind of companies the world genuinely needs.
Lamprna has developed the world’s first lysosome-mediated RNA degrader platform to improve the efficacy of existing and future RNA interfering therapies
Telos Therapeutics is a preclinical-stage biotech company developing highly potent exosome-based therapies for Autoimmunity and Oncology.
InnoVira is developing the world’s first EBV-specific antiviral medication to target the root cause of MS and other EBV-associated conditions like cancer and mononucleosis.
Changing the Standard with a catalog of modular adaptors that clinicians can mix-and-match to create just the right therapy program for their patient – a flexible, adaptive solution.
Biotech is in our DNA
Our team of biotech veterans combines deep scientific expertise with proven company-building experience. We understand both the science and the people behind it and have the experience, empathy and long-term commitment to help both succeed.
Partnerships that bring science to life
We work with academic institutions, investors and industry leaders to help turn breakthrough science into real-world impact. By combining scientific rigour with operational depth, we move faster, build smarter, and bring life-changing therapies to patients.
Inventors lead.
We work with inventors and founders as true partners, for the full journey. Their vision stays at the center of what we do, and we build a structure that helps them thrive and bring their scientific breakthroughs to life.
Inventors lead.
We work with inventors and founders as true partners, for the full journey. Their vision stays at the center of what we do, and we build a structure that helps them thrive and bring their scientific breakthroughs to life.
“Persphoni Biopartners have been an exceptional partner from day one. Their scientific expertise is truly world-class, matched by their outstanding business acumen and ability to secure funding effectively.”
“Every interaction has been with genuinely nice, collaborative people who work together in perfect harmony as a team. The deal process was founder-friendly, transparent, and supportive...”
“...from the very beginning, making us feel valued and understood. Their collaborative approach to deal-making, combined with deep expertise, made the journey not only successful but also enjoyable."